Life Science Company News

Report on transactions with ALK-Abelló A/S B-shares and associated securities by managerial staff

ALK (ALKB:DC / OMX: ALK B / AKABY / AKBLF) reports the following transactions:

1.Details of the person discharging managerial responsibility / person closely associated
a)NameSøren Niegel
2.Reason for the notification
a)Position/statusMember of the Board of Management
b)Initial notification/amendmentInitial notification
3.Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor
a)NameALK-Abelló A/S
4.Details of the transaction(s): section to be repeated for (i) each type of instrument: (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted
a)Description of the financial instrument,
type of instrument

Identification code

b)Nature of the transactionSale
c)Price(s) and volume(s)Price(s)Volume(s)
  DKK 3,090.52 6,514
d)Aggregated information

- Aggregated volume

- Price


DKK 20,131,643
e)Date of the transaction2021-11-25
f)Place of the transactionNasdaq Copenhagen

ALK-Abelló A/S

For further information please contact:

Investor Relations: Per Plotnikof, mobile +45 2261 2525


By: GlobenewsWire - 25 Nov 2021
Back to overview

Enhance your business development with Biotechgate